HCP Live

Articles by HCP Live

Practical Management of Patients at Risk for CVD

ByHCP Live

October 28th 2020

Risk-Enhancing Factors for Lipid Disorders

ByHCP Live

October 28th 2020

Unmet Needs and Emerging Treatments for Psoriasis

ByHCP Live

October 16th 2020

Challenges in Treating Patients With Plaque Psoriasis

ByHCP Live

October 16th 2020

Elderly Male With Plaque Psoriasis, Metabolic Syndrome

ByHCP Live

October 16th 2020

49-Year-Old Female With Psoriasis and Latent Tuberculosis

ByHCP Live

October 16th 2020

Case Study of a 23-Year-Old Female With Plaque Psoriasis

ByHCP Live

October 16th 2020

IL-23 Inhibitors for Treatment of Plaque Psoriasis

ByHCP Live

October 16th 2020

Managing Depression as a Psychological Effect of Psoriasis

ByHCP Live

October 16th 2020

HIV as a Contraindication for Treatment of Psoriasis

ByHCP Live

October 16th 2020

Contraindications to the Conventional Treatment for Psoriasis

ByHCP Live

October 16th 2020

Adverse Events of TNF Inhibitors Used to Treat Psoriasis

ByHCP Live

October 16th 2020

Experience With Using Older Biologics to Treat Psoriasis

ByHCP Live

October 16th 2020

Medical Benefit of Office Administration of Tildrakizumab

ByHCP Live

October 16th 2020

Effect of Multiple Sclerosis and Obesity on Treatment of Psoriasis

ByHCP Live

October 16th 2020

Factors That Influence Choice of Treatment for Plaque Psoriasis

ByHCP Live

October 16th 2020

Clinical Manifestations and Progressive Nature of Psoriasis

ByHCP Live

October 16th 2020

Pathogenesis of Plaque Psoriasis and Triggering Factors

ByHCP Live

October 16th 2020

Summary

ByHCP Live

September 29th 2020

Case Study 3: Non-Radiographic Axial Spondylia Patient Case Overview and Therapeutic Goals

ByHCP Live

September 29th 2020

Case Study 2: Rheumatoid Arthritis Patient Case Overview and Therapeutic Goals

ByHCP Live

September 29th 2020

Case Study 1: Psoriatic Arthritis Patient Case Overview and Therapeutic Goals

ByHCP Live

September 29th 2020

Optimal Management of Hypercholesterolemia

ByHCP Live

September 10th 2020

ACS: Early Intervention With PCSK9 Therapy

ByHCP Live

September 10th 2020

Increasing Confidence in Prescribing PCSK9 Inhibitors

ByHCP Live

September 10th 2020

Real-World Experience With PCSK9 Inhibitors

ByHCP Live

September 10th 2020

Lipoprotein(a) and PCSK9 Utilization

ByHCP Live

September 10th 2020

Cardiovascular Outcomes: FOURIER and ODYSSEY

ByHCP Live

September 10th 2020

PCSK9 Inhibitors and LDL-C Reduction

ByHCP Live

September 10th 2020

HCP Live

Articles by HCP Live

Practical Management of Patients at Risk for CVD

Risk-Enhancing Factors for Lipid Disorders

Unmet Needs and Emerging Treatments for Psoriasis

Challenges in Treating Patients With Plaque Psoriasis

Elderly Male With Plaque Psoriasis, Metabolic Syndrome

49-Year-Old Female With Psoriasis and Latent Tuberculosis

Case Study of a 23-Year-Old Female With Plaque Psoriasis

IL-23 Inhibitors for Treatment of Plaque Psoriasis

Managing Depression as a Psychological Effect of Psoriasis

HIV as a Contraindication for Treatment of Psoriasis

Contraindications to the Conventional Treatment for Psoriasis

Adverse Events of TNF Inhibitors Used to Treat Psoriasis

Experience With Using Older Biologics to Treat Psoriasis

Medical Benefit of Office Administration of Tildrakizumab

Effect of Multiple Sclerosis and Obesity on Treatment of Psoriasis

Factors That Influence Choice of Treatment for Plaque Psoriasis

Clinical Manifestations and Progressive Nature of Psoriasis

Pathogenesis of Plaque Psoriasis and Triggering Factors

Summary

Case Study 3: Non-Radiographic Axial Spondylia Patient Case Overview and Therapeutic Goals

Case Study 2: Rheumatoid Arthritis Patient Case Overview and Therapeutic Goals

Case Study 1: Psoriatic Arthritis Patient Case Overview and Therapeutic Goals

Optimal Management of Hypercholesterolemia

ACS: Early Intervention With PCSK9 Therapy

Increasing Confidence in Prescribing PCSK9 Inhibitors

Real-World Experience With PCSK9 Inhibitors

Lipoprotein(a) and PCSK9 Utilization

Cardiovascular Outcomes: FOURIER and ODYSSEY

PCSK9 Inhibitors and LDL-C Reduction

Managing Intolerance to Statin Therapy

Trending on HCPLive

Bringing Bronchiectasis Guidelines Into Everyday Practice

The Future of Bronchiectasis Care: Precision Medicine Ahead

Does Artificial Intelligence Worsen Health Care Disparities?

Sequencing Therapies for Bronchiectasis: A Practical Approach

Inhaled Antibiotics for Pseudomonas in Bronchiectasis